ChloroquineV1, Istex, Corpus, bibRecord, 002C60

Myasthenia gravis and risks for comorbidity

Identifieur interne : 002C60 ( Istex/Corpus ); précédent : 002C59; suivant : 002C61

Myasthenia gravis and risks for comorbidity

Auteurs : N. E. Gilhus ; A. Nacu ; J. B. Andersen ; J. F. Owe

Source :

European Journal of Neurology [ 1351-5101 ] ; 2015-01.

RBID : ISTEX:7CDDC87B1EB0B85AB9D62DF2AEC50DFCD4A68F88

Abstract

Myasthenia gravis (MG) is an autoimmune disorder leading to skeletal muscle weakness and fatigability. MG subgroups are defined according to pathogenetic autoantibody (against acetylcholine receptor, muscle‐specific tyrosine kinase or lipoprotein receptor‐related protein 4), thymus pathology and clinical manifestations. MG patients have an increased risk for concordant autoimmune disease, in particular with early onset MG. Most common comorbidities are thyroid disease, systemic lupus erythematosus and rheumatoid arthritis. Cardiomyositis and subclinical heart dysfunction have been described in patients with thymoma MG and late onset MG but represent no major threat. A thymic lymphoepithelioma implies an increased risk for another cancer. Autoimmune MG represents no distinct cancer risk factor, although lymphomas and a few other cancer types have been reported with slightly increased frequency. Severe MG‐related muscle weakness means a risk for respiratory failure and respiratory tract infection. Drug MG treatment can lead to side‐effects. Thymectomy is regarded as a safe procedure both short and long term. Non‐MG‐related comorbidity represents a diagnostic and therapeutic challenge, especially in elderly patients. Diagnostic accuracy and optimal follow‐up is necessary to identify and treat all types of coexisting disease in MG.

Url:

https://api.istex.fr/ark:/67375/WNG-8MCRP6C2-Z/fulltext.pdf

DOI: 10.1111/ene.12599

Links to Exploration step

ISTEX:7CDDC87B1EB0B85AB9D62DF2AEC50DFCD4A68F88

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Myasthenia gravis and risks for comorbidity</title>
<author><name sortKey="Gilhus, N E" sort="Gilhus, N E" uniqKey="Gilhus N" first="N. E." last="Gilhus">N. E. Gilhus</name>
<affiliation><mods:affiliation>Department of Clinical Medicine, University of Bergen, Bergen, Norway</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Department of Neurology, Haukeland University Hospital, Bergen, Norway</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>E-mail: nils.gilhus@k1.uib.no</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Nacu, A" sort="Nacu, A" uniqKey="Nacu A" first="A." last="Nacu">A. Nacu</name>
<affiliation><mods:affiliation>Department of Clinical Medicine, University of Bergen, Bergen, Norway</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Department of Neurology, Haukeland University Hospital, Bergen, Norway</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Department of Neurology, State Medical and Pharmaceutical University ‘N Testemitanu’, Chisinau, Moldova</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Andersen, J B" sort="Andersen, J B" uniqKey="Andersen J" first="J. B." last="Andersen">J. B. Andersen</name>
<affiliation><mods:affiliation>Department of Clinical Medicine, University of Bergen, Bergen, Norway</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Owe, J F" sort="Owe, J F" uniqKey="Owe J" first="J. F." last="Owe">J. F. Owe</name>
<affiliation><mods:affiliation>Department of Clinical Medicine, University of Bergen, Bergen, Norway</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Department of Neurology, Haukeland University Hospital, Bergen, Norway</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:7CDDC87B1EB0B85AB9D62DF2AEC50DFCD4A68F88</idno>
<date when="2015" year="2015">2015</date>
<idno type="doi">10.1111/ene.12599</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-8MCRP6C2-Z/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002C60</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002C60</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Myasthenia gravis and risks for comorbidity</title>
<author><name sortKey="Gilhus, N E" sort="Gilhus, N E" uniqKey="Gilhus N" first="N. E." last="Gilhus">N. E. Gilhus</name>
<affiliation><mods:affiliation>Department of Clinical Medicine, University of Bergen, Bergen, Norway</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Department of Neurology, Haukeland University Hospital, Bergen, Norway</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>E-mail: nils.gilhus@k1.uib.no</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Nacu, A" sort="Nacu, A" uniqKey="Nacu A" first="A." last="Nacu">A. Nacu</name>
<affiliation><mods:affiliation>Department of Clinical Medicine, University of Bergen, Bergen, Norway</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Department of Neurology, Haukeland University Hospital, Bergen, Norway</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Department of Neurology, State Medical and Pharmaceutical University ‘N Testemitanu’, Chisinau, Moldova</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Andersen, J B" sort="Andersen, J B" uniqKey="Andersen J" first="J. B." last="Andersen">J. B. Andersen</name>
<affiliation><mods:affiliation>Department of Clinical Medicine, University of Bergen, Bergen, Norway</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Owe, J F" sort="Owe, J F" uniqKey="Owe J" first="J. F." last="Owe">J. F. Owe</name>
<affiliation><mods:affiliation>Department of Clinical Medicine, University of Bergen, Bergen, Norway</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Department of Neurology, Haukeland University Hospital, Bergen, Norway</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">European Journal of Neurology</title>
<title level="j" type="alt">EUROPEAN JOURNAL OF NEUROLOGY</title>
<idno type="ISSN">1351-5101</idno>
<idno type="eISSN">1468-1331</idno>
<imprint><biblScope unit="vol">22</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="17">17</biblScope>
<biblScope unit="page" to="23">23</biblScope>
<biblScope unit="page-count">7</biblScope>
<date type="published" when="2015-01">2015-01</date>
</imprint>
<idno type="ISSN">1351-5101</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1351-5101</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract">Myasthenia gravis (MG) is an autoimmune disorder leading to skeletal muscle weakness and fatigability. MG subgroups are defined according to pathogenetic autoantibody (against acetylcholine receptor, muscle‐specific tyrosine kinase or lipoprotein receptor‐related protein 4), thymus pathology and clinical manifestations. MG patients have an increased risk for concordant autoimmune disease, in particular with early onset MG. Most common comorbidities are thyroid disease, systemic lupus erythematosus and rheumatoid arthritis. Cardiomyositis and subclinical heart dysfunction have been described in patients with thymoma MG and late onset MG but represent no major threat. A thymic lymphoepithelioma implies an increased risk for another cancer. Autoimmune MG represents no distinct cancer risk factor, although lymphomas and a few other cancer types have been reported with slightly increased frequency. Severe MG‐related muscle weakness means a risk for respiratory failure and respiratory tract infection. Drug MG treatment can lead to side‐effects. Thymectomy is regarded as a safe procedure both short and long term. Non‐MG‐related comorbidity represents a diagnostic and therapeutic challenge, especially in elderly patients. Diagnostic accuracy and optimal follow‐up is necessary to identify and treat all types of coexisting disease in MG.</div>
</front>
</TEI>
<istex><corpusName>wiley</corpusName>
<author><json:item><name>N. E. Gilhus</name>
<affiliations><json:string>Department of Clinical Medicine, University of Bergen, Bergen, Norway</json:string>
<json:string>Department of Neurology, Haukeland University Hospital, Bergen, Norway</json:string>
<json:string>E-mail: nils.gilhus@k1.uib.no</json:string>
</affiliations>
</json:item>
<json:item><name>A. Nacu</name>
<affiliations><json:string>Department of Clinical Medicine, University of Bergen, Bergen, Norway</json:string>
<json:string>Department of Neurology, Haukeland University Hospital, Bergen, Norway</json:string>
<json:string>Department of Neurology, State Medical and Pharmaceutical University ‘N Testemitanu’, Chisinau, Moldova</json:string>
</affiliations>
</json:item>
<json:item><name>J. B. Andersen</name>
<affiliations><json:string>Department of Clinical Medicine, University of Bergen, Bergen, Norway</json:string>
</affiliations>
</json:item>
<json:item><name>J. F. Owe</name>
<affiliations><json:string>Department of Clinical Medicine, University of Bergen, Bergen, Norway</json:string>
<json:string>Department of Neurology, Haukeland University Hospital, Bergen, Norway</json:string>
</affiliations>
</json:item>
</author>
<subject><json:item><lang><json:string>eng</json:string>
</lang>
<value>autoimmune disease</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>cancer</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>comorbidity</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>heart disease</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>myasthenia gravis</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>respiratory disease</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>thymoma</value>
</json:item>
</subject>
<articleId><json:string>ENE12599</json:string>
</articleId>
<arkIstex>ark:/67375/WNG-8MCRP6C2-Z</arkIstex>
<language><json:string>eng</json:string>
</language>
<originalGenre><json:string>reviewArticle</json:string>
</originalGenre>
<abstract>Myasthenia gravis (MG) is an autoimmune disorder leading to skeletal muscle weakness and fatigability. MG subgroups are defined according to pathogenetic autoantibody (against acetylcholine receptor, muscle‐specific tyrosine kinase or lipoprotein receptor‐related protein 4), thymus pathology and clinical manifestations. MG patients have an increased risk for concordant autoimmune disease, in particular with early onset MG. Most common comorbidities are thyroid disease, systemic lupus erythematosus and rheumatoid arthritis. Cardiomyositis and subclinical heart dysfunction have been described in patients with thymoma MG and late onset MG but represent no major threat. A thymic lymphoepithelioma implies an increased risk for another cancer. Autoimmune MG represents no distinct cancer risk factor, although lymphomas and a few other cancer types have been reported with slightly increased frequency. Severe MG‐related muscle weakness means a risk for respiratory failure and respiratory tract infection. Drug MG treatment can lead to side‐effects. Thymectomy is regarded as a safe procedure both short and long term. Non‐MG‐related comorbidity represents a diagnostic and therapeutic challenge, especially in elderly patients. Diagnostic accuracy and optimal follow‐up is necessary to identify and treat all types of coexisting disease in MG.</abstract>
<qualityIndicators><score>8.196</score>
<pdfWordCount>3988</pdfWordCount>
<pdfCharCount>26193</pdfCharCount>
<pdfVersion>1.6</pdfVersion>
<pdfPageCount>7</pdfPageCount>
<pdfPageSize>595.276 x 782.362 pts</pdfPageSize>
<pdfWordsPerPage>570</pdfWordsPerPage>
<pdfText>true</pdfText>
<refBibsNative>true</refBibsNative>
<abstractWordCount>184</abstractWordCount>
<abstractCharCount>1349</abstractCharCount>
<keywordCount>7</keywordCount>
</qualityIndicators>
<title>Myasthenia gravis and risks for comorbidity</title>
<genre><json:string>review-article</json:string>
</genre>
<host><title>European Journal of Neurology</title>
<language><json:string>unknown</json:string>
</language>
<doi><json:string>10.1111/(ISSN)1468-1331</json:string>
</doi>
<issn><json:string>1351-5101</json:string>
</issn>
<eissn><json:string>1468-1331</json:string>
</eissn>
<publisherId><json:string>ENE</json:string>
</publisherId>
<volume>22</volume>
<issue>1</issue>
<pages><first>17</first>
<last>23</last>
<total>7</total>
</pages>
<genre><json:string>journal</json:string>
</genre>
<subject><json:item><value>Invited Review</value>
</json:item>
<json:item><value>Invited Reviews</value>
</json:item>
</subject>
</host>
<ark><json:string>ark:/67375/WNG-8MCRP6C2-Z</json:string>
</ark>
<categories><wos><json:string>1 - science</json:string>
<json:string>2 - neurosciences</json:string>
<json:string>2 - clinical neurology</json:string>
</wos>
<scienceMetrix><json:string>1 - health sciences</json:string>
<json:string>2 - clinical medicine</json:string>
<json:string>3 - neurology & neurosurgery</json:string>
</scienceMetrix>
<scopus><json:string>1 - Health Sciences</json:string>
<json:string>2 - Medicine</json:string>
<json:string>3 - Clinical Neurology</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Neuroscience</json:string>
<json:string>3 - Neurology</json:string>
</scopus>
<inist><json:string>1 - sciences appliquees, technologies et medecines</json:string>
<json:string>2 - sciences biologiques et medicales</json:string>
<json:string>3 - sciences medicales</json:string>
</inist>
</categories>
<publicationDate>2015</publicationDate>
<copyrightDate>2015</copyrightDate>
<doi><json:string>10.1111/ene.12599</json:string>
</doi>
<id>7CDDC87B1EB0B85AB9D62DF2AEC50DFCD4A68F88</id>
<score>1</score>
<fulltext><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-8MCRP6C2-Z/fulltext.pdf</uri>
</json:item>
<json:item><extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-8MCRP6C2-Z/bundle.zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-8MCRP6C2-Z/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Myasthenia gravis and risks for comorbidity</title>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher ref="https://scientific-publisher.data.istex.fr/ark:/67375/H02-QW5Q88H5-V">Wiley Publishing Ltd</publisher>
<availability><licence>© 2014 EAN</licence>
</availability>
<date type="published" when="2015-01"></date>
</publicationStmt>
<notesStmt><note type="content-type" subtype="review-article" source="reviewArticle" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</note>
<note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc><biblStruct type="review-article"><analytic><title level="a" type="main">Myasthenia gravis and risks for comorbidity</title>
<author xml:id="author-0000" role="corresp"><persName><forename type="first">N. E.</forename>
<surname>Gilhus</surname>
</persName>
<affiliation><orgName type="division">Department of Clinical Medicine</orgName> 
                        <orgName type="institution">University of Bergen</orgName> 
                        <address><settlement>Bergen</settlement>
<country key="NO" xml:lang="en">NORWAY</country>
</address>
</affiliation>
<affiliation><orgName type="division">Department of Neurology</orgName> 
                        <orgName type="institution">Haukeland University Hospital</orgName> 
                        <address><settlement>Bergen</settlement> 
                           <country key="NO" xml:lang="en">NORWAY</country>
</address>
</affiliation>
</author>
<author xml:id="author-0001"><persName><forename type="first">A.</forename>
<surname>Nacu</surname>
</persName>
<affiliation><orgName type="division">Department of Clinical Medicine</orgName> 
                        <orgName type="institution">University of Bergen</orgName> 
                        <address><settlement>Bergen</settlement>
<country key="NO" xml:lang="en">NORWAY</country>
</address>
</affiliation>
<affiliation><orgName type="division">Department of Neurology</orgName> 
                        <orgName type="institution">Haukeland University Hospital</orgName> 
                        <address><settlement>Bergen</settlement> 
                           <country key="NO" xml:lang="en">NORWAY</country>
</address>
</affiliation>
<affiliation><orgName type="division">Department of Neurology</orgName> 
                        <orgName type="institution">State Medical and Pharmaceutical University ‘N Testemitanu’</orgName> 
                        <address><settlement>Chisinau</settlement> 
                           <country key="MD" xml:lang="en">MOLDOVA, REPUBLIC OF</country>
</address>
</affiliation>
</author>
<author xml:id="author-0002"><persName><forename type="first">J. B.</forename>
<surname>Andersen</surname>
</persName>
<affiliation><orgName type="division">Department of Clinical Medicine</orgName> 
                        <orgName type="institution">University of Bergen</orgName> 
                        <address><settlement>Bergen</settlement>
<country key="NO" xml:lang="en">NORWAY</country>
</address>
</affiliation>
</author>
<author xml:id="author-0003"><persName><forename type="first">J. F.</forename>
<surname>Owe</surname>
</persName>
<affiliation><orgName type="division">Department of Clinical Medicine</orgName> 
                        <orgName type="institution">University of Bergen</orgName> 
                        <address><settlement>Bergen</settlement>
<country key="NO" xml:lang="en">NORWAY</country>
</address>
</affiliation>
<affiliation><orgName type="division">Department of Neurology</orgName> 
                        <orgName type="institution">Haukeland University Hospital</orgName> 
                        <address><settlement>Bergen</settlement> 
                           <country key="NO" xml:lang="en">NORWAY</country>
</address>
</affiliation>
</author>
<idno type="istex">7CDDC87B1EB0B85AB9D62DF2AEC50DFCD4A68F88</idno>
<idno type="ark">ark:/67375/WNG-8MCRP6C2-Z</idno>
<idno type="DOI">10.1111/ene.12599</idno>
<idno type="unit">ENE12599</idno>
<idno type="toTypesetVersion">file:ENE.ENE12599.pdf</idno>
</analytic>
<monogr><title level="j" type="main">European Journal of Neurology</title>
<title level="j" type="alt">EUROPEAN JOURNAL OF NEUROLOGY</title>
<idno type="pISSN">1351-5101</idno>
<idno type="eISSN">1468-1331</idno>
<idno type="book-DOI">10.1111/(ISSN)1468-1331</idno>
<idno type="book-part-DOI">10.1111/ene.2014.22.issue-1</idno>
<idno type="product">ENE</idno>
<imprint><biblScope unit="vol">22</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="17">17</biblScope>
<biblScope unit="page" to="23">23</biblScope>
<biblScope unit="page-count">7</biblScope>
<date type="published" when="2015-01"></date>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef>
<appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-20"><label>pub2TEI-ISTEX</label>
<desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
                        <ref target="http://www.tei-c.org/">We use TEI</ref>
</desc>
</application>
</appInfo>
</encodingDesc>
<profileDesc><abstract style="main" xml:id="ene12599-abs-0001"><p>Myasthenia gravis (<hi rend="fc">MG</hi>
) is an autoimmune disorder leading to skeletal muscle weakness and fatigability. <hi rend="fc">MG</hi>
 subgroups are defined according to pathogenetic autoantibody (against acetylcholine receptor, muscle‐specific tyrosine kinase or lipoprotein receptor‐related protein 4), thymus pathology and clinical manifestations. <hi rend="fc">MG</hi>
 patients have an increased risk for concordant autoimmune disease, in particular with early onset <hi rend="fc">MG</hi>
. Most common comorbidities are thyroid disease, systemic lupus erythematosus and rheumatoid arthritis. Cardiomyositis and subclinical heart dysfunction have been described in patients with thymoma <hi rend="fc">MG</hi>
 and late onset <hi rend="fc">MG</hi>
 but represent no major threat. A thymic lymphoepithelioma implies an increased risk for another cancer. Autoimmune <hi rend="fc">MG</hi>
 represents no distinct cancer risk factor, although lymphomas and a few other cancer types have been reported with slightly increased frequency. Severe <hi rend="fc">MG</hi>
‐related muscle weakness means a risk for respiratory failure and respiratory tract infection. Drug <hi rend="fc">MG</hi>
 treatment can lead to side‐effects. Thymectomy is regarded as a safe procedure both short and long term. Non‐<hi rend="fc">MG</hi>
‐related comorbidity represents a diagnostic and therapeutic challenge, especially in elderly patients. Diagnostic accuracy and optimal follow‐up is necessary to identify and treat all types of coexisting disease in <hi rend="fc">MG</hi>
.</p>
</abstract>
<textClass><keywords><term xml:id="ene12599-kwd-0001">autoimmune disease</term>
<term xml:id="ene12599-kwd-0002">cancer</term>
<term xml:id="ene12599-kwd-0003">comorbidity</term>
<term xml:id="ene12599-kwd-0004">heart disease</term>
<term xml:id="ene12599-kwd-0005">myasthenia gravis</term>
<term xml:id="ene12599-kwd-0006">respiratory disease</term>
<term xml:id="ene12599-kwd-0007">thymoma</term>
</keywords>
<keywords rend="articleCategory"><term>Invited Review</term>
</keywords>
<keywords rend="tocHeading1"><term>Invited Reviews</term>
</keywords>
</textClass>
<langUsage><language ident="en"></language>
</langUsage>
</profileDesc>
<revisionDesc><change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-8MCRP6C2-Z/fulltext.txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document><component type="serialArticle" version="2.0" xml:id="ene12599" xml:lang="en"><header><publicationMeta level="product"><doi origin="wiley" registered="yes">10.1111/(ISSN)1468-1331</doi>
<issn type="print">1351-5101</issn>
<issn type="electronic">1468-1331</issn>
<idGroup><id type="product" value="ENE"></id>
</idGroup>
<titleGroup><title sort="EUROPEAN JOURNAL OF NEUROLOGY" type="main">European Journal of Neurology</title>
<title type="short">Eur J Neurol</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="10"><doi origin="wiley">10.1111/ene.2014.22.issue-1</doi>
<copyright ownership="thirdParty">European Journal of Neurology © 2015 European Academy of Neurology</copyright>
<numberingGroup><numbering type="journalVolume" number="22">22</numbering>
<numbering type="journalIssue">1</numbering>
</numberingGroup>
<coverDate startDate="2015-01">January 2015</coverDate>
</publicationMeta>
<publicationMeta level="unit" position="50" status="forIssue" type="reviewArticle"><doi>10.1111/ene.12599</doi>
<idGroup><id type="unit" value="ENE12599"></id>
</idGroup>
<countGroup><count number="7" type="pageTotal"></count>
</countGroup>
<titleGroup><title type="articleCategory">Invited Review</title>
<title type="tocHeading1">Invited Reviews</title>
</titleGroup>
<copyright ownership="thirdParty">© 2014 EAN</copyright>
<eventGroup><event date="2014-09-15" type="manuscriptReceived"></event>
<event date="2014-09-19" type="manuscriptAccepted"></event>
<event agent="SPS" date="2014-10-14" type="xmlCreated"></event>
<event type="publishedOnlineEarlyUnpaginated" date="2014-10-30"></event>
<event type="firstOnline" date="2014-10-30"></event>
<event type="publishedOnlineFinalForm" date="2014-12-13"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.7.2 mode:FullText" date="2016-01-05"></event>
</eventGroup>
<numberingGroup><numbering type="pageFirst">17</numbering>
<numbering type="pageLast">23</numbering>
</numberingGroup>
<correspondenceTo>Correspondence: N. E. Gilhus, Department of Neurology, Haukeland University Hospital, 5021 Bergen, Norway (tel.: +47 55975000; fax: +47 55975164; e‐mail: <email>nils.gilhus@k1.uib.no</email>
).</correspondenceTo>
<linkGroup><link type="toTypesetVersion" href="file:ENE.ENE12599.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta><titleGroup><title type="main">Myasthenia gravis and risks for comorbidity</title>
<title type="shortAuthors">N. E. Gilhus <i>et al</i>
.</title>
</titleGroup>
<creators><creator affiliationRef="#ene12599-aff-0001 #ene12599-aff-0002" corresponding="yes" creatorRole="author" xml:id="ene12599-cr-0001"><personName><givenNames>N. E.</givenNames>
 <familyName>Gilhus</familyName>
</personName>
</creator>
<creator affiliationRef="#ene12599-aff-0001 #ene12599-aff-0002 #ene12599-aff-0003" creatorRole="author" xml:id="ene12599-cr-0002"><personName><givenNames>A.</givenNames>
 <familyName>Nacu</familyName>
</personName>
</creator>
<creator affiliationRef="#ene12599-aff-0001" creatorRole="author" xml:id="ene12599-cr-0003"><personName><givenNames>J. B.</givenNames>
 <familyName>Andersen</familyName>
</personName>
</creator>
<creator affiliationRef="#ene12599-aff-0001 #ene12599-aff-0002" creatorRole="author" xml:id="ene12599-cr-0004"><personName><givenNames>J. F.</givenNames>
 <familyName>Owe</familyName>
</personName>
</creator>
</creators>
<affiliationGroup><affiliation countryCode="NO" type="organization" xml:id="ene12599-aff-0001"><orgDiv>Department of Clinical Medicine</orgDiv>
 <orgName>University of Bergen</orgName>
 <address><city>Bergen</city>
<country>Norway</country>
</address>
</affiliation>
<affiliation countryCode="NO" type="organization" xml:id="ene12599-aff-0002"><orgDiv>Department of Neurology</orgDiv>
 <orgName>Haukeland University Hospital</orgName>
 <address><city>Bergen</city>
 <country>Norway</country>
</address>
</affiliation>
<affiliation countryCode="MD" type="organization" xml:id="ene12599-aff-0003"><orgDiv>Department of Neurology</orgDiv>
 <orgName>State Medical and Pharmaceutical University ‘N Testemitanu’</orgName>
 <address><city>Chisinau</city>
 <country>Moldova</country>
</address>
</affiliation>
</affiliationGroup>
<keywordGroup type="author"><keyword xml:id="ene12599-kwd-0001">autoimmune disease</keyword>
<keyword xml:id="ene12599-kwd-0002">cancer</keyword>
<keyword xml:id="ene12599-kwd-0003">comorbidity</keyword>
<keyword xml:id="ene12599-kwd-0004">heart disease</keyword>
<keyword xml:id="ene12599-kwd-0005">myasthenia gravis</keyword>
<keyword xml:id="ene12599-kwd-0006">respiratory disease</keyword>
<keyword xml:id="ene12599-kwd-0007">thymoma</keyword>
</keywordGroup>
<abstractGroup><abstract type="main" xml:id="ene12599-abs-0001"><p>Myasthenia gravis (<fc>MG</fc>
) is an autoimmune disorder leading to skeletal muscle weakness and fatigability. <fc>MG</fc>
 subgroups are defined according to pathogenetic autoantibody (against acetylcholine receptor, muscle‐specific tyrosine kinase or lipoprotein receptor‐related protein 4), thymus pathology and clinical manifestations. <fc>MG</fc>
 patients have an increased risk for concordant autoimmune disease, in particular with early onset <fc>MG</fc>
. Most common comorbidities are thyroid disease, systemic lupus erythematosus and rheumatoid arthritis. Cardiomyositis and subclinical heart dysfunction have been described in patients with thymoma <fc>MG</fc>
 and late onset <fc>MG</fc>
 but represent no major threat. A thymic lymphoepithelioma implies an increased risk for another cancer. Autoimmune <fc>MG</fc>
 represents no distinct cancer risk factor, although lymphomas and a few other cancer types have been reported with slightly increased frequency. Severe <fc>MG</fc>
‐related muscle weakness means a risk for respiratory failure and respiratory tract infection. Drug <fc>MG</fc>
 treatment can lead to side‐effects. Thymectomy is regarded as a safe procedure both short and long term. Non‐<fc>MG</fc>
‐related comorbidity represents a diagnostic and therapeutic challenge, especially in elderly patients. Diagnostic accuracy and optimal follow‐up is necessary to identify and treat all types of coexisting disease in <fc>MG</fc>
.</p>
</abstract>
</abstractGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo lang="en"><title>Myasthenia gravis and risks for comorbidity</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en"><title>Myasthenia gravis and risks for comorbidity</title>
</titleInfo>
<name type="personal"><namePart type="given">N. E.</namePart>
<namePart type="family">Gilhus</namePart>
<affiliation>Department of Clinical Medicine, University of Bergen, Bergen, Norway</affiliation>
<affiliation>Department of Neurology, Haukeland University Hospital, Bergen, Norway</affiliation>
<affiliation>E-mail: nils.gilhus@k1.uib.no</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A.</namePart>
<namePart type="family">Nacu</namePart>
<affiliation>Department of Clinical Medicine, University of Bergen, Bergen, Norway</affiliation>
<affiliation>Department of Neurology, Haukeland University Hospital, Bergen, Norway</affiliation>
<affiliation>Department of Neurology, State Medical and Pharmaceutical University ‘N Testemitanu’, Chisinau, Moldova</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J. B.</namePart>
<namePart type="family">Andersen</namePart>
<affiliation>Department of Clinical Medicine, University of Bergen, Bergen, Norway</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J. F.</namePart>
<namePart type="family">Owe</namePart>
<affiliation>Department of Clinical Medicine, University of Bergen, Bergen, Norway</affiliation>
<affiliation>Department of Neurology, Haukeland University Hospital, Bergen, Norway</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="review-article" displayLabel="reviewArticle" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</genre>
<originInfo><publisher>Blackwell Publishing Ltd</publisher>
<dateIssued encoding="w3cdtf">2015-01</dateIssued>
<dateCreated encoding="w3cdtf">2014-10-14</dateCreated>
<dateCaptured encoding="w3cdtf">2014-09-15</dateCaptured>
<dateValid encoding="w3cdtf">2014-09-19</dateValid>
<copyrightDate encoding="w3cdtf">2015</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<abstract>Myasthenia gravis (MG) is an autoimmune disorder leading to skeletal muscle weakness and fatigability. MG subgroups are defined according to pathogenetic autoantibody (against acetylcholine receptor, muscle‐specific tyrosine kinase or lipoprotein receptor‐related protein 4), thymus pathology and clinical manifestations. MG patients have an increased risk for concordant autoimmune disease, in particular with early onset MG. Most common comorbidities are thyroid disease, systemic lupus erythematosus and rheumatoid arthritis. Cardiomyositis and subclinical heart dysfunction have been described in patients with thymoma MG and late onset MG but represent no major threat. A thymic lymphoepithelioma implies an increased risk for another cancer. Autoimmune MG represents no distinct cancer risk factor, although lymphomas and a few other cancer types have been reported with slightly increased frequency. Severe MG‐related muscle weakness means a risk for respiratory failure and respiratory tract infection. Drug MG treatment can lead to side‐effects. Thymectomy is regarded as a safe procedure both short and long term. Non‐MG‐related comorbidity represents a diagnostic and therapeutic challenge, especially in elderly patients. Diagnostic accuracy and optimal follow‐up is necessary to identify and treat all types of coexisting disease in MG.</abstract>
<subject><genre>keywords</genre>
<topic>autoimmune disease</topic>
<topic>cancer</topic>
<topic>comorbidity</topic>
<topic>heart disease</topic>
<topic>myasthenia gravis</topic>
<topic>respiratory disease</topic>
<topic>thymoma</topic>
</subject>
<relatedItem type="host"><titleInfo><title>European Journal of Neurology</title>
</titleInfo>
<titleInfo type="abbreviated"><title>Eur J Neurol</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<subject><genre>article-category</genre>
<topic>Invited Review</topic>
<topic>Invited Reviews</topic>
</subject>
<identifier type="ISSN">1351-5101</identifier>
<identifier type="eISSN">1468-1331</identifier>
<identifier type="DOI">10.1111/(ISSN)1468-1331</identifier>
<identifier type="PublisherID">ENE</identifier>
<part><date>2015</date>
<detail type="volume"><caption>vol.</caption>
<number>22</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>17</start>
<end>23</end>
<total>7</total>
</extent>
</part>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0001"><titleInfo><title>Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity</title>
</titleInfo>
<name type="personal"><namePart type="given">MN</namePart>
<namePart type="family">Meriggioli</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">DB</namePart>
<namePart type="family">Sanders</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 2009; 8: 475–499.</note>
<part><date>2009</date>
<detail type="volume"><caption>vol.</caption>
<number>8</number>
</detail>
<extent unit="pages"><start>475</start>
<end>499</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Lancet Neurol</title>
</titleInfo>
<part><date>2009</date>
<detail type="volume"><caption>vol.</caption>
<number>8</number>
</detail>
<extent unit="pages"><start>475</start>
<end>499</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0002"><titleInfo><title>Myasthenia and neuromuscular junction</title>
</titleInfo>
<name type="personal"><namePart type="given">NE</namePart>
<namePart type="family">Gilhus</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Gilhus NE. Myasthenia and neuromuscular junction. Curr Opin Neurol 2012; 25: 523–529.</note>
<part><date>2012</date>
<detail type="volume"><caption>vol.</caption>
<number>25</number>
</detail>
<extent unit="pages"><start>523</start>
<end>529</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Curr Opin Neurol</title>
</titleInfo>
<part><date>2012</date>
<detail type="volume"><caption>vol.</caption>
<number>25</number>
</detail>
<extent unit="pages"><start>523</start>
<end>529</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0003"><titleInfo><title>Myasthenia and the neuromuscular junction</title>
</titleInfo>
<name type="personal"><namePart type="given">L</namePart>
<namePart type="family">Querol</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">I</namePart>
<namePart type="family">Illa</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Querol L, Illa I. Myasthenia and the neuromuscular junction. Curr Opin Neurol 2013; 26: 459–465.</note>
<part><date>2013</date>
<detail type="volume"><caption>vol.</caption>
<number>26</number>
</detail>
<extent unit="pages"><start>459</start>
<end>465</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Curr Opin Neurol</title>
</titleInfo>
<part><date>2013</date>
<detail type="volume"><caption>vol.</caption>
<number>26</number>
</detail>
<extent unit="pages"><start>459</start>
<end>465</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0004"><titleInfo><title>The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes</title>
</titleInfo>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Marx</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">P</namePart>
<namePart type="family">Pfister</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">B</namePart>
<namePart type="family">Schalke</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Marx A, Pfister P, Schalke B, et al. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev 2013; 12: 875–884.</note>
<part><date>2013</date>
<detail type="volume"><caption>vol.</caption>
<number>12</number>
</detail>
<extent unit="pages"><start>875</start>
<end>884</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Autoimmun Rev</title>
</titleInfo>
<part><date>2013</date>
<detail type="volume"><caption>vol.</caption>
<number>12</number>
</detail>
<extent unit="pages"><start>875</start>
<end>884</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0005"><titleInfo><title>Seropositive myasthenia gravis; a nationwide epidemiologic study</title>
</titleInfo>
<name type="personal"><namePart type="given">AT</namePart>
<namePart type="family">Heldal</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JF</namePart>
<namePart type="family">Owe</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">NE</namePart>
<namePart type="family">Gilhus</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Heldal AT, Owe JF, Gilhus NE, et al. Seropositive myasthenia gravis; a nationwide epidemiologic study. Neurology 2009; 73: 150–151.</note>
<part><date>2009</date>
<detail type="volume"><caption>vol.</caption>
<number>73</number>
</detail>
<extent unit="pages"><start>150</start>
<end>151</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Neurology</title>
</titleInfo>
<part><date>2009</date>
<detail type="volume"><caption>vol.</caption>
<number>73</number>
</detail>
<extent unit="pages"><start>150</start>
<end>151</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0006"><titleInfo><title>A systematic review of population based epidemiological studies in myasthenia gravis</title>
</titleInfo>
<name type="personal"><namePart type="given">AS</namePart>
<namePart type="family">Carr</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">CR</namePart>
<namePart type="family">Cardwell</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PO</namePart>
<namePart type="family">McCarron</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Carr AS, Cardwell CR, McCarron PO, et al. A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol 2010; 10: 46.</note>
<part><date>2010</date>
<detail type="volume"><caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages"><start>46</start>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>BMC Neurol</title>
</titleInfo>
<part><date>2010</date>
<detail type="volume"><caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages"><start>46</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0007"><titleInfo><title>Increasing incidence of myasthenia gravis among elderly in British Columbia, Canada</title>
</titleInfo>
<name type="personal"><namePart type="given">Z</namePart>
<namePart type="family">Pakzad</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Aziz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Oger</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Pakzad Z, Aziz T, Oger J. Increasing incidence of myasthenia gravis among elderly in British Columbia, Canada. Neurology 2011; 76: 1526–1528.</note>
<part><date>2011</date>
<detail type="volume"><caption>vol.</caption>
<number>76</number>
</detail>
<extent unit="pages"><start>1526</start>
<end>1528</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Neurology</title>
</titleInfo>
<part><date>2011</date>
<detail type="volume"><caption>vol.</caption>
<number>76</number>
</detail>
<extent unit="pages"><start>1526</start>
<end>1528</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0008"><titleInfo><title>Late‐onset myasthenia not on the increase: a nationwide register study in Denmark, 1996–2009</title>
</titleInfo>
<name type="personal"><namePart type="given">EG</namePart>
<namePart type="family">Pedersen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Hallas</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">K</namePart>
<namePart type="family">Hansen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Pedersen EG, Hallas J, Hansen K, et al. Late‐onset myasthenia not on the increase: a nationwide register study in Denmark, 1996–2009. Eur J Neurol 2012; 20: 942–948.</note>
<part><date>2012</date>
<detail type="volume"><caption>vol.</caption>
<number>20</number>
</detail>
<extent unit="pages"><start>942</start>
<end>948</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Eur J Neurol</title>
</titleInfo>
<part><date>2012</date>
<detail type="volume"><caption>vol.</caption>
<number>20</number>
</detail>
<extent unit="pages"><start>942</start>
<end>948</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0009"><titleInfo><title>Guidelines for treatment of autoimmune neuromuscular transmission disorders</title>
</titleInfo>
<name type="personal"><namePart type="given">GO</namePart>
<namePart type="family">Skeie</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Apostolski</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Evoli</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Skeie GO, Apostolski S, Evoli A, et al. Guidelines for treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol 2010; 17: 893–902.</note>
<part><date>2010</date>
<detail type="volume"><caption>vol.</caption>
<number>17</number>
</detail>
<extent unit="pages"><start>893</start>
<end>902</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Eur J Neurol</title>
</titleInfo>
<part><date>2010</date>
<detail type="volume"><caption>vol.</caption>
<number>17</number>
</detail>
<extent unit="pages"><start>893</start>
<end>902</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0010"><titleInfo><title>Advances in the treatment of myasthenia gravis</title>
</titleInfo>
<name type="personal"><namePart type="given">NE</namePart>
<namePart type="family">Gilhus</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Gilhus NE. Advances in the treatment of myasthenia gravis. Future Neurol 2012; 7: 701–708.</note>
<part><date>2012</date>
<detail type="volume"><caption>vol.</caption>
<number>7</number>
</detail>
<extent unit="pages"><start>701</start>
<end>708</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Future Neurol</title>
</titleInfo>
<part><date>2012</date>
<detail type="volume"><caption>vol.</caption>
<number>7</number>
</detail>
<extent unit="pages"><start>701</start>
<end>708</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0011"><titleInfo><title>Acute treatment for myasthenia gravis</title>
</titleInfo>
<name type="personal"><namePart type="given">NE</namePart>
<namePart type="family">Gilhus</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Gilhus NE. Acute treatment for myasthenia gravis. Nat Rev Neurol 2011; 7: 132–134.</note>
<part><date>2011</date>
<detail type="volume"><caption>vol.</caption>
<number>7</number>
</detail>
<extent unit="pages"><start>132</start>
<end>134</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Nat Rev Neurol</title>
</titleInfo>
<part><date>2011</date>
<detail type="volume"><caption>vol.</caption>
<number>7</number>
</detail>
<extent unit="pages"><start>132</start>
<end>134</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0012"><titleInfo><title>Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001</title>
</titleInfo>
<name type="personal"><namePart type="given">JF</namePart>
<namePart type="family">Owe</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AK</namePart>
<namePart type="family">Daltveit</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">NE</namePart>
<namePart type="family">Gilhus</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Owe JF, Daltveit AK, Gilhus NE. Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001. J Neurol Neurosurg Psychiatry 2006; 77: 203–207.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>77</number>
</detail>
<extent unit="pages"><start>203</start>
<end>207</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J Neurol Neurosurg Psychiatry</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>77</number>
</detail>
<extent unit="pages"><start>203</start>
<end>207</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0013"><titleInfo><title>Concomitant autoimmunity in myasthenia gravis – lack of association with IgA deficiency</title>
</titleInfo>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Ramanujam</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">F</namePart>
<namePart type="family">Piehl</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Pirskanen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PK</namePart>
<namePart type="family">Gregersen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">L</namePart>
<namePart type="family">Hammarstrom</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ramanujam R, Piehl F, Pirskanen R, Gregersen PK, Hammarstrom L. Concomitant autoimmunity in myasthenia gravis – lack of association with IgA deficiency. J Neuroimmunol 2011; 236: 118–122.</note>
<part><date>2011</date>
<detail type="volume"><caption>vol.</caption>
<number>236</number>
</detail>
<extent unit="pages"><start>118</start>
<end>122</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J Neuroimmunol</title>
</titleInfo>
<part><date>2011</date>
<detail type="volume"><caption>vol.</caption>
<number>236</number>
</detail>
<extent unit="pages"><start>118</start>
<end>122</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0014"><titleInfo><title>Frequency of autoimmune diseases in myasthenia gravis: a systematic review</title>
</titleInfo>
<name type="personal"><namePart type="given">ZF</namePart>
<namePart type="family">Mao</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">LX</namePart>
<namePart type="family">Yang</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">XA</namePart>
<namePart type="family">Mo</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Mao ZF, Yang LX, Mo XA, et al. Frequency of autoimmune diseases in myasthenia gravis: a systematic review. Int J Neurosci 2011; 121: 121–129.</note>
<part><date>2011</date>
<detail type="volume"><caption>vol.</caption>
<number>121</number>
</detail>
<extent unit="pages"><start>121</start>
<end>129</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Int J Neurosci</title>
</titleInfo>
<part><date>2011</date>
<detail type="volume"><caption>vol.</caption>
<number>121</number>
</detail>
<extent unit="pages"><start>121</start>
<end>129</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0015"><titleInfo><title>The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature</title>
</titleInfo>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Jallouli</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Saadoun</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">B</namePart>
<namePart type="family">Eymard</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Jallouli M, Saadoun D, Eymard B, et al. The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature. J Neurol 2012; 259: 1290–1297.</note>
<part><date>2012</date>
<detail type="volume"><caption>vol.</caption>
<number>259</number>
</detail>
<extent unit="pages"><start>1290</start>
<end>1297</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J Neurol</title>
</titleInfo>
<part><date>2012</date>
<detail type="volume"><caption>vol.</caption>
<number>259</number>
</detail>
<extent unit="pages"><start>1290</start>
<end>1297</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0016"><titleInfo><title>Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity</title>
</titleInfo>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Sardu</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">E</namePart>
<namePart type="family">Cocco</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Mereu</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Sardu C, Cocco E, Mereu A, et al. Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity. PLoS One 2012; 7: e32487.</note>
<part><date>2012</date>
<detail type="volume"><caption>vol.</caption>
<number>7</number>
</detail>
<extent unit="pages"><start>e32487</start>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>PLoS One</title>
</titleInfo>
<part><date>2012</date>
<detail type="volume"><caption>vol.</caption>
<number>7</number>
</detail>
<extent unit="pages"><start>e32487</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0017"><titleInfo><title>Total drug treatment and comorbidity in myasthenia gravis; a population‐based cohort study</title>
</titleInfo>
<name type="personal"><namePart type="given">JA</namePart>
<namePart type="family">Andersen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JF</namePart>
<namePart type="family">Owe</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Engeland</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">NE</namePart>
<namePart type="family">Gilhus</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Andersen JA, Owe JF, Engeland A, Gilhus NE. Total drug treatment and comorbidity in myasthenia gravis; a population‐based cohort study. Eur J Neurol 2014; 21: 948–955.</note>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>21</number>
</detail>
<extent unit="pages"><start>948</start>
<end>955</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Eur J Neurol</title>
</titleInfo>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>21</number>
</detail>
<extent unit="pages"><start>948</start>
<end>955</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0018"><titleInfo><title>Genomewide study of multiple sclerosis</title>
</titleInfo>
<name type="personal"><namePart type="given">SV</namePart>
<namePart type="family">Ramagopalan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Anderson</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AD</namePart>
<namePart type="family">Sadovnick</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">GC</namePart>
<namePart type="family">Ebers</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ramagopalan SV, Anderson C, Sadovnick AD, Ebers GC. Genomewide study of multiple sclerosis. N Engl J Med 2007; 357: 2199–2200.</note>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>357</number>
</detail>
<extent unit="pages"><start>2199</start>
<end>2200</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>N Engl J Med</title>
</titleInfo>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>357</number>
</detail>
<extent unit="pages"><start>2199</start>
<end>2200</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0019"><titleInfo><title>Associated conditions in myasthenia gravis: response to thymectomy</title>
</titleInfo>
<name type="personal"><namePart type="given">JF</namePart>
<namePart type="family">Tellez‐Zenteno</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Cardenas</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">B</namePart>
<namePart type="family">Estanol</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Garcia‐Ramos</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">N</namePart>
<namePart type="family">Weder‐Cisneros</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Tellez‐Zenteno JF, Cardenas G, Estanol B, Garcia‐Ramos G, Weder‐Cisneros N. Associated conditions in myasthenia gravis: response to thymectomy. Eur J Neurol 2004; 11: 767–773.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>11</number>
</detail>
<extent unit="pages"><start>767</start>
<end>773</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Eur J Neurol</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>11</number>
</detail>
<extent unit="pages"><start>767</start>
<end>773</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0020"><titleInfo><title>Susceptibility of ocular tissues to autoimmune diseases</title>
</titleInfo>
<name type="personal"><namePart type="given">HJ</namePart>
<namePart type="family">Kaminski</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Z</namePart>
<namePart type="family">Li</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Richmonds</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">RL</namePart>
<namePart type="family">Ruff</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">L</namePart>
<namePart type="family">Kusner</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Kaminski HJ, Li Z, Richmonds C, Ruff RL, Kusner L. Susceptibility of ocular tissues to autoimmune diseases. Ann N Y Acad Sci 2003; 998: 362–374.</note>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>998</number>
</detail>
<extent unit="pages"><start>362</start>
<end>374</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Ann N Y Acad Sci</title>
</titleInfo>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>998</number>
</detail>
<extent unit="pages"><start>362</start>
<end>374</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0021"><titleInfo><title>Clinical features of myasthenia gravis patients with autoimmune thyroid disease in Taiwan</title>
</titleInfo>
<name type="personal"><namePart type="given">YL</namePart>
<namePart type="family">Chen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JH</namePart>
<namePart type="family">Yeh</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">HC</namePart>
<namePart type="family">Chiu</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Chen YL, Yeh JH, Chiu HC. Clinical features of myasthenia gravis patients with autoimmune thyroid disease in Taiwan. Acta Neurol Scand 2013; 127: 170–174.</note>
<part><date>2013</date>
<detail type="volume"><caption>vol.</caption>
<number>127</number>
</detail>
<extent unit="pages"><start>170</start>
<end>174</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Acta Neurol Scand</title>
</titleInfo>
<part><date>2013</date>
<detail type="volume"><caption>vol.</caption>
<number>127</number>
</detail>
<extent unit="pages"><start>170</start>
<end>174</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0022"><titleInfo><title>Recent findings on systemic autoimmune diseases</title>
</titleInfo>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Delgado‐Vega</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">E</namePart>
<namePart type="family">Sanchez</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Löfgren</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Castillejo‐Lopez</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">ME</namePart>
<namePart type="family">Alarcon‐Riquelme</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Delgado‐Vega A, Sanchez E, Löfgren S, Castillejo‐Lopez C, Alarcon‐Riquelme ME. Recent findings on systemic autoimmune diseases. Curr Opin Immunol 2010; 22: 698–705.</note>
<part><date>2010</date>
<detail type="volume"><caption>vol.</caption>
<number>22</number>
</detail>
<extent unit="pages"><start>698</start>
<end>705</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Curr Opin Immunol</title>
</titleInfo>
<part><date>2010</date>
<detail type="volume"><caption>vol.</caption>
<number>22</number>
</detail>
<extent unit="pages"><start>698</start>
<end>705</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0023"><titleInfo><title>A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica</title>
</titleInfo>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Iyer</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">L</namePart>
<namePart type="family">Elsone</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Appleton</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Jacob</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Iyer A, Elsone L, Appleton R, Jacob A. A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica. Autoimmunity 2014; 47: 154–161.</note>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>47</number>
</detail>
<extent unit="pages"><start>154</start>
<end>161</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Autoimmunity</title>
</titleInfo>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>47</number>
</detail>
<extent unit="pages"><start>154</start>
<end>161</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0024"><titleInfo><title>Clinical implications of shared genetics and pathogenesis in autoimmune diseases</title>
</titleInfo>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Zhermakova</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Withoff</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Wijmenga</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Zhermakova A, Withoff S, Wijmenga C. Clinical implications of shared genetics and pathogenesis in autoimmune diseases. Nat Rev Endocrinol 2013; 9: 645–659.</note>
<part><date>2013</date>
<detail type="volume"><caption>vol.</caption>
<number>9</number>
</detail>
<extent unit="pages"><start>645</start>
<end>659</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Nat Rev Endocrinol</title>
</titleInfo>
<part><date>2013</date>
<detail type="volume"><caption>vol.</caption>
<number>9</number>
</detail>
<extent unit="pages"><start>645</start>
<end>659</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0025"><titleInfo><title>Risk for myasthenia gravis maps to a (151) Pro‐Ala change in TNIP1 and to human leukocyte antigen‐B*08</title>
</titleInfo>
<name type="personal"><namePart type="given">PK</namePart>
<namePart type="family">Gregersen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Kosoy</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AT</namePart>
<namePart type="family">Lee</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Gregersen PK, Kosoy R, Lee AT, et al. Risk for myasthenia gravis maps to a (151) Pro‐Ala change in TNIP1 and to human leukocyte antigen‐B*08. Ann Neurol 2012; 72: 927–935.</note>
<part><date>2012</date>
<detail type="volume"><caption>vol.</caption>
<number>72</number>
</detail>
<extent unit="pages"><start>927</start>
<end>935</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Ann Neurol</title>
</titleInfo>
<part><date>2012</date>
<detail type="volume"><caption>vol.</caption>
<number>72</number>
</detail>
<extent unit="pages"><start>927</start>
<end>935</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0026"><titleInfo><title>Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms</title>
</titleInfo>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Berrih‐Aknin</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Le Panse</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Berrih‐Aknin S, Le Panse R. Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun 2014; 52: 90–100.</note>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>52</number>
</detail>
<extent unit="pages"><start>90</start>
<end>100</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J Autoimmun</title>
</titleInfo>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>52</number>
</detail>
<extent unit="pages"><start>90</start>
<end>100</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0027"><titleInfo><title>Statins may aggravate myasthenia gravis</title>
</titleInfo>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Oh</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Dhall</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Young</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Oh SJ, Dhall R, Young A, et al. Statins may aggravate myasthenia gravis. Muscle Nerve 2008; 38: 1101–1107.</note>
<part><date>2008</date>
<detail type="volume"><caption>vol.</caption>
<number>38</number>
</detail>
<extent unit="pages"><start>1101</start>
<end>1107</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Muscle Nerve</title>
</titleInfo>
<part><date>2008</date>
<detail type="volume"><caption>vol.</caption>
<number>38</number>
</detail>
<extent unit="pages"><start>1101</start>
<end>1107</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0028"><titleInfo><title>Is it safe to use statins in myasthenia gravis?</title>
</titleInfo>
<name type="personal"><namePart type="given">NE</namePart>
<namePart type="family">Gilhus</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Gilhus NE. Is it safe to use statins in myasthenia gravis? Nat Clin Pract 2009; 5: 8–9.</note>
<part><date>2009</date>
<detail type="volume"><caption>vol.</caption>
<number>5</number>
</detail>
<extent unit="pages"><start>8</start>
<end>9</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Nat Clin Pract</title>
</titleInfo>
<part><date>2009</date>
<detail type="volume"><caption>vol.</caption>
<number>5</number>
</detail>
<extent unit="pages"><start>8</start>
<end>9</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0029"><titleInfo><title>The co‐existence of myasthenia gravis in patients with myositis: a case series</title>
</titleInfo>
<name type="personal"><namePart type="given">JJ</namePart>
<namePart type="family">Paik</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AM</namePart>
<namePart type="family">Corse</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AL</namePart>
<namePart type="family">Mammen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Paik JJ, Corse AM, Mammen AL. The co‐existence of myasthenia gravis in patients with myositis: a case series. Semin Arthritis and Rheum 2014; 43: 792–796.</note>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>43</number>
</detail>
<extent unit="pages"><start>792</start>
<end>796</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Semin Arthritis and Rheum</title>
</titleInfo>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>43</number>
</detail>
<extent unit="pages"><start>792</start>
<end>796</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0030"><titleInfo><title>Giant cell polymyositis and myocarditis associated with myasthenia gravis and thymoma</title>
</titleInfo>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Kon</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">F</namePart>
<namePart type="family">Mori</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">K</namePart>
<namePart type="family">Tanji</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Kon T, Mori F, Tanji K, et al. Giant cell polymyositis and myocarditis associated with myasthenia gravis and thymoma. Neuropathology 2013; 33: 281–287.</note>
<part><date>2013</date>
<detail type="volume"><caption>vol.</caption>
<number>33</number>
</detail>
<extent unit="pages"><start>281</start>
<end>287</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Neuropathology</title>
</titleInfo>
<part><date>2013</date>
<detail type="volume"><caption>vol.</caption>
<number>33</number>
</detail>
<extent unit="pages"><start>281</start>
<end>287</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0031"><titleInfo><title>Cardiac involvements in myasthenia gravis associated with anti‐Kv1.4 antibodies</title>
</titleInfo>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Suzuki</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Baba</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">K</namePart>
<namePart type="family">Kaida</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Suzuki S, Baba A, Kaida K, et al. Cardiac involvements in myasthenia gravis associated with anti‐Kv1.4 antibodies. Eur J Neurol 2014; 21: 223–230.</note>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>21</number>
</detail>
<extent unit="pages"><start>223</start>
<end>230</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Eur J Neurol</title>
</titleInfo>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>21</number>
</detail>
<extent unit="pages"><start>223</start>
<end>230</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0032"><titleInfo><title>Overlooked non‐motor symptoms in myasthenia gravis</title>
</titleInfo>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Suzuki</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">K</namePart>
<namePart type="family">Utsugisawa</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">N</namePart>
<namePart type="family">Suzuki</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Suzuki S, Utsugisawa K, Suzuki N. Overlooked non‐motor symptoms in myasthenia gravis. J Neurol Neurosurg Psychiatry 2013; 84: 989–994.</note>
<part><date>2013</date>
<detail type="volume"><caption>vol.</caption>
<number>84</number>
</detail>
<extent unit="pages"><start>989</start>
<end>994</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J Neurol Neurosurg Psychiatry</title>
</titleInfo>
<part><date>2013</date>
<detail type="volume"><caption>vol.</caption>
<number>84</number>
</detail>
<extent unit="pages"><start>989</start>
<end>994</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0033"><titleInfo><title>Cardiac disease in myasthenia gravis: a literature review</title>
</titleInfo>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Guglin</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JV</namePart>
<namePart type="family">Campellone</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">K</namePart>
<namePart type="family">Heintz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JE</namePart>
<namePart type="family">Parrillo</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Guglin M, Campellone JV, Heintz K, Parrillo JE. Cardiac disease in myasthenia gravis: a literature review. J Clin Neuromuscul Dis 2003; 4: 199–203.</note>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>4</number>
</detail>
<extent unit="pages"><start>199</start>
<end>203</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J Clin Neuromuscul Dis</title>
</titleInfo>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>4</number>
</detail>
<extent unit="pages"><start>199</start>
<end>203</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0034"><titleInfo><title>Left ventricular function in myasthenia gravis</title>
</titleInfo>
<name type="personal"><namePart type="given">K</namePart>
<namePart type="family">Johannessen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Å</namePart>
<namePart type="family">Mygland</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">NE</namePart>
<namePart type="family">Gilhus</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Aarli</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Vik‐Mo</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Johannessen K, Mygland Å, Gilhus NE, Aarli J, Vik‐Mo H. Left ventricular function in myasthenia gravis. Am J Cardiol 1992; 69: 129–132.</note>
<part><date>1992</date>
<detail type="volume"><caption>vol.</caption>
<number>69</number>
</detail>
<extent unit="pages"><start>129</start>
<end>132</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Am J Cardiol</title>
</titleInfo>
<part><date>1992</date>
<detail type="volume"><caption>vol.</caption>
<number>69</number>
</detail>
<extent unit="pages"><start>129</start>
<end>132</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0035"><titleInfo><title>Left ventricular long‐axis function in myasthenia gravis</title>
</titleInfo>
<name type="personal"><namePart type="given">JF</namePart>
<namePart type="family">Owe</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">ES</namePart>
<namePart type="family">Davidsen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">GE</namePart>
<namePart type="family">Eide</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">E</namePart>
<namePart type="family">Gerdts</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">NE</namePart>
<namePart type="family">Gilhus</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Owe JF, Davidsen ES, Eide GE, Gerdts E, Gilhus NE. Left ventricular long‐axis function in myasthenia gravis. J Neurol 2008; 255: 1777–1784.</note>
<part><date>2008</date>
<detail type="volume"><caption>vol.</caption>
<number>255</number>
</detail>
<extent unit="pages"><start>1777</start>
<end>1784</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J Neurol</title>
</titleInfo>
<part><date>2008</date>
<detail type="volume"><caption>vol.</caption>
<number>255</number>
</detail>
<extent unit="pages"><start>1777</start>
<end>1784</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0036"><titleInfo><title>Heart rate and heart pressure variability in patients with myasthenia gravis</title>
</titleInfo>
<name type="personal"><namePart type="given">SP</namePart>
<namePart type="family">Puneeth</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SR</namePart>
<namePart type="family">Chandra</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Yadav</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">TN</namePart>
<namePart type="family">Stahyaprabha</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Chandran</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Puneeth SP, Chandra SR, Yadav R, Stahyaprabha TN, Chandran S. Heart rate and heart pressure variability in patients with myasthenia gravis. Ann Indian Acad Neurol 2013; 16: 329–332.</note>
<part><date>2013</date>
<detail type="volume"><caption>vol.</caption>
<number>16</number>
</detail>
<extent unit="pages"><start>329</start>
<end>332</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Ann Indian Acad Neurol</title>
</titleInfo>
<part><date>2013</date>
<detail type="volume"><caption>vol.</caption>
<number>16</number>
</detail>
<extent unit="pages"><start>329</start>
<end>332</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0037"><titleInfo><title>Risk of extrathymic cancer in patients with myasthenia gravis in Taiwan: a nationwide population‐based study</title>
</titleInfo>
<name type="personal"><namePart type="given">CJ</namePart>
<namePart type="family">Liu</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">YS</namePart>
<namePart type="family">Chang</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">CJ</namePart>
<namePart type="family">Teng</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Liu CJ, Chang YS, Teng CJ, et al. Risk of extrathymic cancer in patients with myasthenia gravis in Taiwan: a nationwide population‐based study. Eur J Neurol 2012; 19: 746–751.</note>
<part><date>2012</date>
<detail type="volume"><caption>vol.</caption>
<number>19</number>
</detail>
<extent unit="pages"><start>746</start>
<end>751</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Eur J Neurol</title>
</titleInfo>
<part><date>2012</date>
<detail type="volume"><caption>vol.</caption>
<number>19</number>
</detail>
<extent unit="pages"><start>746</start>
<end>751</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0038"><titleInfo><title>Myasthenia and risk of cancer: a population‐based case−control study</title>
</titleInfo>
<name type="personal"><namePart type="given">EG</namePart>
<namePart type="family">Pedersen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Pottegard</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">I</namePart>
<namePart type="family">Hallas</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Pedersen EG, Pottegard A, Hallas I, et al. Myasthenia and risk of cancer: a population‐based case−control study. Eur J Neurol 2014; 21: 773–778.</note>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>21</number>
</detail>
<extent unit="pages"><start>773</start>
<end>778</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Eur J Neurol</title>
</titleInfo>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>21</number>
</detail>
<extent unit="pages"><start>773</start>
<end>778</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0039"><titleInfo><title>Excessive risk of cancer and in particular lymphoid malignancy in myasthenia gravis pateints: a population‐based cohort study</title>
</titleInfo>
<name type="personal"><namePart type="given">JH</namePart>
<namePart type="family">Yeh</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">CC</namePart>
<namePart type="family">Lin</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">YK</namePart>
<namePart type="family">Chen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">FC</namePart>
<namePart type="family">Sung</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">HC</namePart>
<namePart type="family">Chiu</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">CH</namePart>
<namePart type="family">Kao</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Yeh JH, Lin CC, Chen YK, Sung FC, Chiu HC, Kao CH. Excessive risk of cancer and in particular lymphoid malignancy in myasthenia gravis pateints: a population‐based cohort study. Neuromuscul Disord 2014; 24: 245–249.</note>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>24</number>
</detail>
<extent unit="pages"><start>245</start>
<end>249</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Neuromuscul Disord</title>
</titleInfo>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>24</number>
</detail>
<extent unit="pages"><start>245</start>
<end>249</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0040"><titleInfo><title>Extrathymic malignancies in thymoma patients with and without myasthenia gravis</title>
</titleInfo>
<name type="personal"><namePart type="given">JF</namePart>
<namePart type="family">Owe</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Cvancarova</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">F</namePart>
<namePart type="family">Romi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">NE</namePart>
<namePart type="family">Gilhus</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Owe JF, Cvancarova M, Romi F, Gilhus NE. Extrathymic malignancies in thymoma patients with and without myasthenia gravis. J Neurol Sci 2010; 290: 66–69.</note>
<part><date>2010</date>
<detail type="volume"><caption>vol.</caption>
<number>290</number>
</detail>
<extent unit="pages"><start>66</start>
<end>69</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J Neurol Sci</title>
</titleInfo>
<part><date>2010</date>
<detail type="volume"><caption>vol.</caption>
<number>290</number>
</detail>
<extent unit="pages"><start>66</start>
<end>69</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0041"><titleInfo><title>Use of azathioprine for non‐thymoma myasthenia and risk of cancer: a nationwide case−control study in Denmark</title>
</titleInfo>
<name type="personal"><namePart type="given">EG</namePart>
<namePart type="family">Pedersen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Pottegard</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Hallas</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Pedersen EG, Pottegard A, Hallas J, et al. Use of azathioprine for non‐thymoma myasthenia and risk of cancer: a nationwide case−control study in Denmark. Eur J Neurol 2013; 20: 942–948.</note>
<part><date>2013</date>
<detail type="volume"><caption>vol.</caption>
<number>20</number>
</detail>
<extent unit="pages"><start>942</start>
<end>948</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Eur J Neurol</title>
</titleInfo>
<part><date>2013</date>
<detail type="volume"><caption>vol.</caption>
<number>20</number>
</detail>
<extent unit="pages"><start>942</start>
<end>948</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0042"><titleInfo><title>Risk of non‐melanoma skin cancer in myasthenia patients treated with azathioprine</title>
</titleInfo>
<name type="personal"><namePart type="given">EG</namePart>
<namePart type="family">Pedersen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Pottegard</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Hallas</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Pedersen EG, Pottegard A, Hallas J, et al. Risk of non‐melanoma skin cancer in myasthenia patients treated with azathioprine. Eur J Neurol 2014; 21: 454–458.</note>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>21</number>
</detail>
<extent unit="pages"><start>454</start>
<end>458</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Eur J Neurol</title>
</titleInfo>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>21</number>
</detail>
<extent unit="pages"><start>454</start>
<end>458</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0043"><titleInfo><title>Autoimmunity associated with immunotherapy of cancer</title>
</titleInfo>
<name type="personal"><namePart type="given">SM</namePart>
<namePart type="family">Amos</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">CPM</namePart>
<namePart type="family">Duong</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JA</namePart>
<namePart type="family">Westwood</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Amos SM, Duong CPM, Westwood JA, et al. Autoimmunity associated with immunotherapy of cancer. Blood 2011; 118: 499–509.</note>
<part><date>2011</date>
<detail type="volume"><caption>vol.</caption>
<number>118</number>
</detail>
<extent unit="pages"><start>499</start>
<end>509</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Blood</title>
</titleInfo>
<part><date>2011</date>
<detail type="volume"><caption>vol.</caption>
<number>118</number>
</detail>
<extent unit="pages"><start>499</start>
<end>509</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0044"><titleInfo><title>Autoimmunity vs. cancer: predator vs. alien</title>
</titleInfo>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Berens</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">K</namePart>
<namePart type="family">Lauber</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Herrmann</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Berens C, Lauber K, Herrmann M. Autoimmunity vs. cancer: predator vs. alien. Autoimmunity 2013; 46: 287–293.</note>
<part><date>2013</date>
<detail type="volume"><caption>vol.</caption>
<number>46</number>
</detail>
<extent unit="pages"><start>287</start>
<end>293</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Autoimmunity</title>
</titleInfo>
<part><date>2013</date>
<detail type="volume"><caption>vol.</caption>
<number>46</number>
</detail>
<extent unit="pages"><start>287</start>
<end>293</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0045"><titleInfo><title>Can cancer trigger autoimmunity?</title>
</titleInfo>
<name type="personal"><namePart type="given">MWL</namePart>
<namePart type="family">Teng</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">MJ</namePart>
<namePart type="family">Smyth</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Teng MWL, Smyth MJ. Can cancer trigger autoimmunity? Science 2014; 343: 147–148.</note>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>343</number>
</detail>
<extent unit="pages"><start>147</start>
<end>148</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Science</title>
</titleInfo>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>343</number>
</detail>
<extent unit="pages"><start>147</start>
<end>148</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0046"><titleInfo><title>Paraneoplastic neuromuscular disorders</title>
</titleInfo>
<name type="personal"><namePart type="given">L</namePart>
<namePart type="family">Sharp</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Vernino</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Sharp L, Vernino S. Paraneoplastic neuromuscular disorders. Muscle Nerve 2012; 46: 841–850.</note>
<part><date>2012</date>
<detail type="volume"><caption>vol.</caption>
<number>46</number>
</detail>
<extent unit="pages"><start>841</start>
<end>850</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Muscle Nerve</title>
</titleInfo>
<part><date>2012</date>
<detail type="volume"><caption>vol.</caption>
<number>46</number>
</detail>
<extent unit="pages"><start>841</start>
<end>850</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0047"><titleInfo><title>Do neuronal autoantibodies cause psychosis: a neuroimmunological perspective</title>
</titleInfo>
<name type="personal"><namePart type="given">E</namePart>
<namePart type="family">Coutinho</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">P</namePart>
<namePart type="family">Harrison</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Vincent</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Coutinho E, Harrison P, Vincent A. Do neuronal autoantibodies cause psychosis: a neuroimmunological perspective. Biol Psychiatry 2014; 75: 269–275.</note>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>75</number>
</detail>
<extent unit="pages"><start>269</start>
<end>275</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Biol Psychiatry</title>
</titleInfo>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>75</number>
</detail>
<extent unit="pages"><start>269</start>
<end>275</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0048"><titleInfo><title>Autoimmune encephalitis</title>
</titleInfo>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Vincent</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Vincent A. Autoimmune encephalitis. J Neurol Neurosurg Psychiatry 2014; 85: e3.</note>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>85</number>
</detail>
<extent unit="pages"><start>e3</start>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J Neurol Neurosurg Psychiatry</title>
</titleInfo>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>85</number>
</detail>
<extent unit="pages"><start>e3</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0049"><titleInfo><title>The epidemiologic evidence linking autoimmune diseases and psychosis</title>
</titleInfo>
<name type="personal"><namePart type="given">ME</namePart>
<namePart type="family">Benros</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">WW</namePart>
<namePart type="family">Eaton</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PB</namePart>
<namePart type="family">Mortensen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Benros ME, Eaton WW, Mortensen PB. The epidemiologic evidence linking autoimmune diseases and psychosis. Biol Psychiatry 2014; 75: 300–306.</note>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>75</number>
</detail>
<extent unit="pages"><start>300</start>
<end>306</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Biol Psychiatry</title>
</titleInfo>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>75</number>
</detail>
<extent unit="pages"><start>300</start>
<end>306</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0050"><titleInfo><title>Psychiatric disorders in myasthenia gravis</title>
</titleInfo>
<name type="personal"><namePart type="given">MI</namePart>
<namePart type="family">Ybarra</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Kummer</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">ERC</namePart>
<namePart type="family">Frota</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JTD</namePart>
<namePart type="family">Oliveira</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">RS</namePart>
<namePart type="family">Gomez</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AL</namePart>
<namePart type="family">Texeira</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ybarra MI, Kummer A, Frota ERC, Oliveira JTD, Gomez RS, Texeira AL. Psychiatric disorders in myasthenia gravis. Arq Neuropsiquiatr 2011; 69: 176–179.</note>
<part><date>2011</date>
<detail type="volume"><caption>vol.</caption>
<number>69</number>
</detail>
<extent unit="pages"><start>176</start>
<end>179</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Arq Neuropsiquiatr</title>
</titleInfo>
<part><date>2011</date>
<detail type="volume"><caption>vol.</caption>
<number>69</number>
</detail>
<extent unit="pages"><start>176</start>
<end>179</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0051"><titleInfo><title>Assessment of health‐related quality of life in patients with myasthenia gravis in Belgrade (Serbia)</title>
</titleInfo>
<name type="personal"><namePart type="given">IZ</namePart>
<namePart type="family">Basta</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">TD</namePart>
<namePart type="family">Pekmezovic</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SZ</namePart>
<namePart type="family">Peric</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Basta IZ, Pekmezovic TD, Peric SZ, et al. Assessment of health‐related quality of life in patients with myasthenia gravis in Belgrade (Serbia). Neurol Sci 2012; 33: 1375–1381.</note>
<part><date>2012</date>
<detail type="volume"><caption>vol.</caption>
<number>33</number>
</detail>
<extent unit="pages"><start>1375</start>
<end>1381</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Neurol Sci</title>
</titleInfo>
<part><date>2012</date>
<detail type="volume"><caption>vol.</caption>
<number>33</number>
</detail>
<extent unit="pages"><start>1375</start>
<end>1381</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0052"><titleInfo><title>Amyotrophic lateral sclerosis with positive anti‐acetylcholine receptor antibodies: case report and review of the literature</title>
</titleInfo>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Mehanna</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">EL</namePart>
<namePart type="family">Patton</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Phan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Y</namePart>
<namePart type="family">Harati</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Mehanna R, Patton EL, Phan C, Harati Y. Amyotrophic lateral sclerosis with positive anti‐acetylcholine receptor antibodies: case report and review of the literature. J Clin Neuromuscul Dis 2012; 14: 82–85.</note>
<part><date>2012</date>
<detail type="volume"><caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages"><start>82</start>
<end>85</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J Clin Neuromuscul Dis</title>
</titleInfo>
<part><date>2012</date>
<detail type="volume"><caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages"><start>82</start>
<end>85</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0053"><titleInfo><title>Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study</title>
</titleInfo>
<name type="personal"><namePart type="given">MR</namePart>
<namePart type="family">Turner</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Goldacre</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Ramagopalan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">K</namePart>
<namePart type="family">Talbot</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">MJ</namePart>
<namePart type="family">Goldacre</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Turner MR, Goldacre R, Ramagopalan S, Talbot K, Goldacre MJ. Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology 2013; 81: 1222–12125.</note>
<part><date>2013</date>
<detail type="volume"><caption>vol.</caption>
<number>81</number>
</detail>
<extent unit="pages"><start>1222</start>
<end>12125</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Neurology</title>
</titleInfo>
<part><date>2013</date>
<detail type="volume"><caption>vol.</caption>
<number>81</number>
</detail>
<extent unit="pages"><start>1222</start>
<end>12125</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0054"><titleInfo><title>No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis</title>
</titleInfo>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Goris</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JV</namePart>
<namePart type="family">Setten</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">F</namePart>
<namePart type="family">Diekstra</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Goris A, Setten JV, Diekstra F, et al. No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis. Hum Mol Genet 2014; 23: 7.</note>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>23</number>
</detail>
<extent unit="pages"><start>7</start>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Hum Mol Genet</title>
</titleInfo>
<part><date>2014</date>
<detail type="volume"><caption>vol.</caption>
<number>23</number>
</detail>
<extent unit="pages"><start>7</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0055"><titleInfo><title>Lifetime course of myasthenia gravis</title>
</titleInfo>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Grob</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">N</namePart>
<namePart type="family">Brunner</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Namba</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Pagala</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve 2008; 37: 141–149.</note>
<part><date>2008</date>
<detail type="volume"><caption>vol.</caption>
<number>37</number>
</detail>
<extent unit="pages"><start>141</start>
<end>149</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Muscle Nerve</title>
</titleInfo>
<part><date>2008</date>
<detail type="volume"><caption>vol.</caption>
<number>37</number>
</detail>
<extent unit="pages"><start>141</start>
<end>149</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0056"><titleInfo><title>Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals</title>
</titleInfo>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Alshekhlee</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JD</namePart>
<namePart type="family">Miles</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">B</namePart>
<namePart type="family">Katirji</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">HC</namePart>
<namePart type="family">Preston</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">HJ</namePart>
<namePart type="family">Kaminski</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Alshekhlee A, Miles JD, Katirji B, Preston HC, Kaminski HJ. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology 2009; 72: 1548–1554.</note>
<part><date>2009</date>
<detail type="volume"><caption>vol.</caption>
<number>72</number>
</detail>
<extent unit="pages"><start>1548</start>
<end>1554</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Neurology</title>
</titleInfo>
<part><date>2009</date>
<detail type="volume"><caption>vol.</caption>
<number>72</number>
</detail>
<extent unit="pages"><start>1548</start>
<end>1554</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="ene12599-cit-0057"><titleInfo><title>Risk of fracture in patients with myasthenia gravis: the general practice research database</title>
</titleInfo>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Pouwels</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Javald</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AD</namePart>
<namePart type="family">Boer</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Pouwels S, Javald M, Boer AD, et al. Risk of fracture in patients with myasthenia gravis: the general practice research database. Bone 2011; 48(Suppl. 2): 270.</note>
<part><date>2011</date>
<detail type="volume"><caption>vol.</caption>
<number>48</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>Suppl. 2</number>
</detail>
<extent unit="pages"><start>270</start>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Bone</title>
</titleInfo>
<part><date>2011</date>
<detail type="volume"><caption>vol.</caption>
<number>48</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>Suppl. 2</number>
</detail>
<extent unit="pages"><start>270</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<identifier type="istex">7CDDC87B1EB0B85AB9D62DF2AEC50DFCD4A68F88</identifier>
<identifier type="ark">ark:/67375/WNG-8MCRP6C2-Z</identifier>
<identifier type="DOI">10.1111/ene.12599</identifier>
<identifier type="ArticleID">ENE12599</identifier>
<accessCondition type="use and reproduction" contentType="copyright">European Journal of Neurology © 2015 European Academy of Neurology© 2014 EAN</accessCondition>
<recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource>
<recordOrigin>Converted from  (version ) to MODS version 3.6.</recordOrigin>
<recordCreationDate encoding="w3cdtf">2019-11-14</recordCreationDate>
</recordInfo>
</mods>
<json:item><extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-8MCRP6C2-Z/record.json</uri>
</json:item>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C60 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002C60 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:7CDDC87B1EB0B85AB9D62DF2AEC50DFCD4A68F88
   |texte=   Myasthenia gravis and risks for comorbidity
}}

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021

	Serveur d'exploration Chloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Chloroquine

Myasthenia gravis and risks for comorbidity

Myasthenia gravis and risks for comorbidity

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri